Biotech Hangout cover image

Episode 59

Biotech Hangout

00:00

The CEO's Call Out of a BAML Analyst

T.G. therapeutics reported positive Q1 earnings, outlook on lead candidate Breumvie. CEO basically took the analyst to task and called out errors in his model. Usually this type of stance for management can come across as defensive.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app